Sharekhan

RPG Life Sciences Ltd

Mon 3/11/2025,15:56:35 NSE: RPGLIFE

₹ 2441.00 37.10 (1.54%)
BUY NOW Buy RPG Life Sciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock RPG Life Sciences Ltd

Mon 3/11/2025,16:1:0

RPG Life Sciences Ltd

Mon 3/11/2025,15:56:35 | NSE : RPGLIFE

₹ 2441.0037.10 (1.54%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 2413.50

Previous Close

₹ 2403.90

Volume

5554

Mkt Cap ( Rs. Cr)

₹4037.17

High

₹ 2465.00

Low

₹ 2399.70

52 Week High

₹ 2744.80

52 Week Low

₹ 1835.00

Book Value Per Share

₹ 229.39

Dividend Yield

0.98

Face Value

₹ 8.00

What’s Your Call?

Collective community sentiment on RPG Life Sciences Ltd

Your Vote -

Buy

55.56%

Hold

11.11%

Sell

33.33%

55.56%

9 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

2441.00

162

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

162

Option Chain

Analyzes market sentiment, predicts RPG Life Sciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    24 Oct 2025, 7:25PM The company has informed about Transcript of Earnings call held on 17th October 2025.

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Oct 2025, 7:24PM The Company has informed the Exchange about Transcript of Earnings call held on 17th October 2025

  • RPG Life Sciences - Spurt in Volume

    21 Oct 2025, 9:43PM Significant increase in volume has been observed in RPG Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant in

  • RPG Life Sciences - Spurt in Volume

    21 Oct 2025, 2:36PM Significant increase in volume has been observed in RPG Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant in

  • RPG Life Sciences has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    21 Oct 2025, 1:20PM As of September 2025, 72.95% is owned by Indian Promoters and 27.05% by Public. <p align=justify> Institutional holds 7.81% (Insurance Companies 0.21%

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    18 Oct 2025, 2:43PM The Company has informed about the recording of Earnings Call.

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Oct 2025, 2:43PM RPG Life Sciences Limited has informed the Exchange about Link of Recording and outcome of Earning call

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    18 Oct 2025, 2:42PM The Company has informed about the recording of Earnings Call.

  • RPG Life Sciences - Copy of Newspaper Publication

    18 Oct 2025, 2:25PM Newspaper Publication

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    17 Oct 2025, 8:32PM Press Release

  • RPG Life Sciences - Resignation

    17 Oct 2025, 6:28PM RPG Life Sciences Limited has informed the Exchange regarding Resignation of Mr Vishal Shah as Chief Financial Officer of the company w.e.f. October 2

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

    17 Oct 2025, 6:28PM Change in Key Managerial Personnel

  • RPG Life Sciences - Press Release

    17 Oct 2025, 6:15PM RPG Life Sciences Limited has informed the Exchange regarding a press release dated October 17, 2025, titled ""Press Release "".

  • RPG Life Sciences Q2 net profit zooms 777.38% at Rs 36.85 cr

    17 Oct 2025, 6:10PM The company reported standalone net profit of Rs 36.85 crore for the quarter ended September 30, 2025 as compared to Rs 4.20 crore in the same period

  • RPG Life Sciences - Investor Presentation

    17 Oct 2025, 6:09PM RPG Life Sciences Limited has informed the Exchange about Investor Presentation

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation

    17 Oct 2025, 6:09PM Investors Presentation

  • RPG Life Sciences - Outcome of Board Meeting

    17 Oct 2025, 6:03PM RPG Life Sciences Limited has submitted to the Exchange, the financial results for the quarter and Half year ended September 30, 2025.

  • RPG Life Sciences - RPG Life Sciences Limited Has Submitted To The Exchange, The Financial Results For The Quarter And Half Y

    17 Oct 2025, 6:00PM Financial Result

  • RPG Life Sciences - Outcome of Board Meeting

    17 Oct 2025, 5:54PM RPG Life Sciences Limited has informed the Exchange regarding Board meeting held on October 17, 2025.

  • RPG Life Sciences - Board Meeting Outcome for Outcome Of Board Meeting Held On October 17, 2025

    17 Oct 2025, 5:53PM Outcome of Board Meeting held on October 17, 2025

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    14 Oct 2025, 1:33PM RPG Life Sciences Limited has informed the Exchange about Schedule of meet

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    14 Oct 2025, 1:40PM Intimation of Earning call for Q2 FY26 scheduled on October 17, 2025 .

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Oct 2025, 6:57PM Intimation for Q2FY26 Results Earnings Call Scheduled on October 17, 2025.

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Oct 2025, 6:57PM RPG Life Sciences Limited has informed the Exchange about Schedule of meet

  • RPG Life Sciences - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    10 Oct 2025, 5:09PM Company has informed about Reg 74(5) of SEBI DP Regulations 2018.

  • RPG Life Sciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    10 Oct 2025, 5:06PM Company has informed about Reg 74(5) of SEBI (DP) Regulations 2018

  • RPG Life Sciences - Board Meeting Intimation for Board Meeting Intimation For RPG Life Sciences Limited To Consider And Appr

    10 Oct 2025, 5:01PM RPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2025 ,inter alia, to consider an

  • RPG Life Sciences - Trading Window

    25 Sep 2025, 5:40PM RPG Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations

  • RPG Life Sciences - Copy of Newspaper Publication

    17 Sep 2025, 7:42PM Newspaper publication for reminding about Special Window for re-lodgement of Physical Share Transfer Requests

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    1 Sep 2025, 7:38PM Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, the details

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    1 Sep 2025, 7:32PM RPG Life Sciences Limited has informed the Exchange about Schedule of meet

  • RPG Life Sciences - Updates

    20 Aug 2025, 10:29PM Intimation regarding 100 Days Campaign - ""Saksham Niveshak""

  • RPG Life Sciences - Intimation Regarding 100 Days Campaign - \Saksham Niveshak\

    20 Aug 2025, 10:26PM Intimation regarding 100 Days Campaign - \Saksham Niveshak\

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Aug 2025, 5:29PM Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, the details

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 Aug 2025, 5:35PM Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, the details
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of RPG Life Sciences Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 530.53 374.85 307.61 256.06 217.71
Liabilities 530.53 374.85 307.61 256.06 217.71
Equity 13.23 13.23 13.23 13.23 13.23
Gross Profit 159.65 128.15 102.69 86.36 69.93
Net Profit 183.24 87.66 67.64 51.48 40
Cash From Operating Activities 77.86 94.36 90.82 64.75 58.27
NPM(%) 28.04 15.06 13.19 11.69 10.27
Revenue 653.43 582.05 512.81 440.16 389.14
Expenses 493.78 453.9 410.12 353.8 319.21
ROE(%) 48.29 23.1 17.82 13.56 10.54

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
27 Jun 2025 4 50 0.98 2091.3
27 Jun 2025 20 250 0.98 2174.5
28 Jun 2024 16 200 0.98 1546.4
14 Jul 2022 9.6 120 0.98 590.65
13 Aug 2021 7.2 90 0.98 485.1
24 Mar 2020 4 50 0.98 219.05
22 Jul 2019 2.4 30 0.98 234.7
19 Jul 2018 2.4 30 0.98 412.1
13 Jul 2017 2.8 35 0.98 440.15
22 Mar 2016 1.6 20 0.98 252.3
20 Jul 2015 0.8 10 0.98 140.15
11 Sep 2014 1.2 15 0.98 70.6
11 Jul 2013 1.2 15 0.98 61.55
24 Jul 2012 0.8 10 0.98 64
14 Jul 2011 1.6 20 0.98 80
15 Jul 2010 1.44 18 0.98 70.65
30 Jul 2009 1.2 15 0.98 31.35
11 Aug 2008 1.2 15 0.98 25.75

Peers

Other companies within the same industry or sector that are comparable to RPG Life Sciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 883.05 3.90 80.06 1390.05 301.39 0.57
Lotus Eye Hospital and Institute Ltd 131.17 4.91 423.13 5065.15 3.55 0.00
Vaishali Pharma Ltd 10.00 -0.40 333.33 31775.35 3.13 0.00
Astec Lifesciences Ltd 672.25 1.85 0.00 4776.55 -604.77 0.00

Company Info

2009 - Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009. 2010 - Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company. - Mr. Sachin Raole, General Manager Finance has been designated as Chief Financial Officer (CFO) of the Company. 2011 - RPG Life Sciences launches dialysis deferring drug. - Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company. 2012 -Board has recommended an equity dividend of Rs. 0.80 per share (10%). 2013 -RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility." -RPG Life Sciences bagged "Asia's Best Employer Brand Awards 2013" in Singapore. 2014 -Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014. 2015 -RPG Life Plans Skincare Foray 2016 -RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic Industry -RPG Life gains over 14 pct on getting EUGMP certification -RPG Life Sciences - RPG Life Sciences to expand its formulations business 2019 -RPG Life Sciences enters Anti-Diabetic therapeutic area.

2009 - Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009. 2010 - Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company. - Mr. Sachin Raole, General Manager Finance has been designated as Chief Financial Officer (CFO) of the Company. 2011 - RPG Life Sciences launches dialysis deferring drug. - Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company. 2012 -Board has recommended an equity dividend of Rs. 0.80 per share (10%). 2013 -RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility." -RPG Life Sciences bagged "Asia's Best Employer Brand Awards 2013" in Singapore. 2014 -Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014. 2015 -RPG Life Plans Skincare Foray 2016 -RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic Industry -RPG Life gains over 14 pct on getting EUGMP certification -RPG Life Sciences - RPG Life Sciences to expand its formulations business 2019 -RPG Life Sciences enters Anti-Diabetic therapeutic area.

Read More

Parent Organisation

RPG Life Sciences Ltd.

Founded

29/03/2007

Managing Director

Mr.Ashok Nair

NSE Symbol

RPGLIFEEQ

FAQ

The current price of RPG Life Sciences Ltd is ₹ 2441.00.

The 52-week high for RPG Life Sciences Ltd is ₹ 2465.00 and the 52-week low is ₹ 2399.70.

The market capitalization of RPG Life Sciences Ltd is currently ₹ 4037.17. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy RPG Life Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in RPG Life Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase RPG Life Sciences Ltd shares.

The CEO of RPG Life Sciences Ltd is Mr.Ashok Nair, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT